{"id":"https://openalex.org/W4200451376","doi":"https://doi.org/10.1016/j.jconrel.2021.12.029","title":"BiTE secretion from in situ-programmed myeloid cells results in tumor-retained pharmacology","display_name":"BiTE secretion from in situ-programmed myeloid cells results in tumor-retained pharmacology","publication_year":2021,"publication_date":"2021-12-23","ids":{"openalex":"https://openalex.org/W4200451376","doi":"https://doi.org/10.1016/j.jconrel.2021.12.029","pmid":"https://pubmed.ncbi.nlm.nih.gov/34953983","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8840964"},"language":"en","primary_location":{"id":"doi:10.1016/j.jconrel.2021.12.029","doi":"https://doi.org/10.1016/j.jconrel.2021.12.029","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2021.12.029","pdf_url":null,"source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.jconrel.2021.12.029","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035832797","display_name":"Shuai Hao","orcid":"https://orcid.org/0000-0003-4942-2215","observed_orcids":["https://orcid.org/0000-0003-4942-2215","https://orcid.org/0000-0001-8168-8908"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Hao","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102769371","display_name":"Vaishali V. Inamdar","orcid":"https://orcid.org/0000-0002-3049-1977","observed_orcids":["https://orcid.org/0000-0002-3049-1977"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"V.V. Inamdar","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002120279","display_name":"Elena C. Sigmund","orcid":"https://orcid.org/0000-0001-5647-879X","observed_orcids":["https://orcid.org/0000-0001-5647-879X"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E.C. Sigmund","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100403443","display_name":"Fan Zhang","orcid":"https://orcid.org/0000-0002-2491-3600","observed_orcids":["https://orcid.org/0000-0002-2491-3600"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. Zhang","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071645691","display_name":"Sirkka B. Stephan","orcid":"https://orcid.org/0009-0008-3800-3748","observed_orcids":["https://orcid.org/0009-0008-3800-3748"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S.B. Stephan","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Watson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Watson","raw_affiliation_strings":["Comparative Pathology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comparative Pathology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109532659","display_name":"Stephanie Weaver","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S.J. Weaver","raw_affiliation_strings":["Experimental Histopathology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Histopathology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":null,"display_name":"U.B. Nielsen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"U.B. Nielsen","raw_affiliation_strings":["Tidal Therapeutics (A Sanofi Company), 270 Albany St, Cambridge, MA 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tidal Therapeutics (A Sanofi Company), 270 Albany St, Cambridge, MA 02139, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063788144","display_name":"Matthias T. Stephan","orcid":"https://orcid.org/0000-0001-8310-0100","observed_orcids":["https://orcid.org/0000-0001-8310-0100"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"M.T. Stephan","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA 98195, USA; Department of Bioengineering and Molecular Engineering & Sciences Institute, University of Washington, Seattle 98195, WA, USA. Electronic address: mstephan@fredhutch.org","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA","Department of Bioengineering and Molecular Engineering & Sciences Institute, University of Washington, Seattle 98195, WA, USA","Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA 98195, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA 98195, USA; Department of Bioengineering and Molecular Engineering & Sciences Institute, University of Washington, Seattle 98195, WA, USA. Electronic address: mstephan@fredhutch.org","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Department of Bioengineering and Molecular Engineering & Sciences Institute, University of Washington, Seattle 98195, WA, USA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA 98195, USA","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5063788144"],"corresponding_institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"],"apc_list":{"value":4540,"currency":"USD","value_usd":4540},"apc_paid":{"value":4540,"currency":"USD","value_usd":4540},"fwci":0.4905,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.56116101,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"342","issue":null,"first_page":"14","last_page":"25"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.5346999764442444,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.5346999764442444,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.1696999967098236,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.15060000121593475,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.9980000257492065},{"id":"https://openalex.org/keywords/in-situ-gene-therapy","display_name":"in situ gene therapy","score":0.8999999761581421},{"id":"https://openalex.org/keywords/myeloid-cells","display_name":"myeloid cells","score":0.9049999713897705},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.7919999957084656},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9100000262260437},{"id":"https://openalex.org/keywords/on-target-off-tumor-toxicity","display_name":"on-target off-tumor toxicity","score":0.8899999856948853},{"id":"https://openalex.org/keywords/tumor-antigen-targeting","display_name":"tumor antigen targeting","score":0.4180000126361847},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.7760000228881836},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.49900001287460327},{"id":"https://openalex.org/keywords/in-vitro-transcribed-mrna","display_name":"in vitro transcribed mRNA","score":0.6919999718666077}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.7360577583312988},{"id":"https://openalex.org/C10679952","wikidata":"https://www.wikidata.org/wiki/Q5308937","display_name":"Druggability","level":3,"score":0.6400432586669922},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5863822102546692},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5767310261726379},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5535728931427002},{"id":"https://openalex.org/C18150654","wikidata":"https://www.wikidata.org/wiki/Q17153796","display_name":"Nanocarriers","level":3,"score":0.49921131134033203},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.41076135635375977},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37388700246810913},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36652952432632446},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.32925331592559814},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28667059540748596},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08769050240516663},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D022423","descriptor_name":"Myeloid Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.jconrel.2021.12.029","doi":"https://doi.org/10.1016/j.jconrel.2021.12.029","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2021.12.029","pdf_url":null,"source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},{"id":"pmid:34953983","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34953983","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of controlled release : official journal of the Controlled Release Society","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8840964","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8840964","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Control Release","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1016/j.jconrel.2021.12.029","doi":"https://doi.org/10.1016/j.jconrel.2021.12.029","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2021.12.029","pdf_url":null,"source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1933502172","display_name":"Developing macrophage reprogramming mRNA nanocarriers for initial clinical testing","funder_award_id":"R01CA263524","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7581823216","display_name":"Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers","funder_award_id":"R01CA207407","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000880613","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA015704","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000888921","display_name":"Rational in situ programming of cancer vaccine-responding T-cell clones","funder_award_id":"R01CA261858","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W54660304","https://openalex.org/W191828198","https://openalex.org/W1596163114","https://openalex.org/W1983085370","https://openalex.org/W1990767426","https://openalex.org/W2054790573","https://openalex.org/W2058647478","https://openalex.org/W2069115249","https://openalex.org/W2073435178","https://openalex.org/W2082401167","https://openalex.org/W2109793454","https://openalex.org/W2118371851","https://openalex.org/W2147947369","https://openalex.org/W2166608208","https://openalex.org/W2171249989","https://openalex.org/W2192049920","https://openalex.org/W2473435857","https://openalex.org/W2571138221","https://openalex.org/W2580706718","https://openalex.org/W2586167822","https://openalex.org/W2590978913","https://openalex.org/W2591709377","https://openalex.org/W2769145099","https://openalex.org/W2778365636","https://openalex.org/W2794055210","https://openalex.org/W2892174208","https://openalex.org/W2947249571","https://openalex.org/W2948996626","https://openalex.org/W2963298310","https://openalex.org/W2978078817","https://openalex.org/W2999300004","https://openalex.org/W3000443771","https://openalex.org/W3004539389","https://openalex.org/W3014980845","https://openalex.org/W3034081173","https://openalex.org/W3104085757","https://openalex.org/W3121960229","https://openalex.org/W3156412251","https://openalex.org/W3177171472","https://openalex.org/W6676414729"],"related_works":["https://openalex.org/W4386399140","https://openalex.org/W4415823323","https://openalex.org/W3125017398","https://openalex.org/W4406875247","https://openalex.org/W4400362010","https://openalex.org/W4404064211","https://openalex.org/W4404064848","https://openalex.org/W2954199150","https://openalex.org/W2566868519","https://openalex.org/W4223505503"],"abstract_inverted_index":{"Bispecific":[0],"T-Cell":[1],"Engagers":[2],"(BiTEs)":[3],"are":[4],"effective":[5],"at":[6,128,184],"inducing":[7],"remission":[8],"in":[9,15,30,63,86,143,148,152],"hematologic":[10],"cancers,":[11],"but":[12],"their":[13,23],"use":[14],"solid":[16,36],"tumors":[17,37],"has":[18],"been":[19],"challenging":[20],"due":[21,176],"to":[22,68,102,111,131,165,177,192],"extreme":[24],"potency":[25],"and":[26,49,113,139],"on-target,":[27],"off-tumor":[28],"toxicities":[29],"healthy":[31],"tissue.":[32],"Their":[33],"deployment":[34],"against":[35],"is":[38,77],"further":[39],"complicated":[40],"by":[41],"insufficient":[42],"drug":[43],"penetration,":[44],"a":[45,73,161],"hostile":[46],"tumor":[47,82,103,168,190],"microenvironment,":[48],"immune":[50,198],"escape.":[51],"To":[52],"address":[53],"these":[54,97],"challenges,":[55],"we":[56],"developed":[57],"targeted":[58],"nanocarriers":[59],"that":[60,76,94,170],"can":[61],"deliver":[62],"vitro-transcribed":[64],"mRNA":[65],"encoding":[66],"BiTEs":[67],"host":[69],"myeloid":[70],"cells":[71],"-":[72,159,164],"cell":[74],"type":[75],"actively":[78],"recruited":[79],"into":[80],"the":[81,107,149,178,185,189],"microenvironment.":[83],"We":[84],"demonstrate":[85],"an":[87],"immunocompetent":[88],"mouse":[89],"model":[90],"of":[91,96,124,180,196],"ovarian":[92],"cancer,":[93],"infusion":[95],"nanoparticles":[98],"directs":[99],"BiTE":[100,126],"expression":[101],"sites,":[104],"which":[105],"reshapes":[106],"microenvironment":[108],"from":[109],"suppressive":[110],"permissive":[112],"triggers":[114],"disease":[115],"regression":[116],"without":[117],"systemic":[118,136],"toxicity.":[119],"In":[120],"contrast,":[121],"conventional":[122],"injections":[123],"recombinant":[125],"protein":[127],"doses":[129],"required":[130],"achieve":[132],"anti-tumor":[133],"activity,":[134],"induced":[135],"inflammatory":[137],"responses":[138],"severe":[140],"tissue":[141],"damage":[142],"all":[144],"treated":[145],"animals.":[146],"Implemented":[147],"clinic,":[150],"this":[151],"situ":[153],"gene":[154],"therapy":[155],"could":[156],"enable":[157],"physicians":[158],"with":[160],"single":[162],"therapeutic":[163],"safely":[166],"target":[167],"antigen":[169],"would":[171],"otherwise":[172],"not":[173],"be":[174],"druggable":[175],"risks":[179],"on-target":[181],"toxicity":[182],"and,":[183],"same":[186],"time,":[187],"reset":[188],"milieu":[191],"boost":[193],"key":[194],"mediators":[195],"antitumor":[197],"responses.":[199]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-12-31T00:00:00"}